Press monitoring
Credit: peter_waters - Fotolia.com
Deconstructing the bee stinger to develop tiny, bio-inspired medical devices
18.8.2023 | Press monitoring
New research deconstructing the anatomy of a honeybee stinger could help pave the way for a future generation of miniaturized medical devices used for drug delivery in humans. Published in the journal iScience, the high-resolution 3D deconstructions produced by University of New South Wales Canberra researchers reveal the unique properties of the...
Nanozymes drive tumor-specific drug delivery while minimizing toxicity
16.8.2023 | Press monitoring
Chemotherapy is a mainstay of cancer treatment. While effective, this therapy indiscriminately kills rapidly dividing cells – cancerous or otherwise – so patients frequently experience severe side effects, ultimately limiting its utility. But what if there was a way to administer an inactive chemotherapeutic throughout the body and 'turn on'...
Credit: © lhyrchel - Fotolia.com
This plant may be a surprise hero in our fight against fungal pathogens
14.8.2023 | Press monitoring
After viruses and bacteria, fungus is the most deadly pathogen and, much like bacteria, is adapting fast to be resistant to current medical interventions. While the official numbers show that around 8,000 Americans die from fungal infections each year, it’s likely to be much higher, since many cases go undiagnosed and, as an ‘opportunistic...
Credit: Norman Lange - Fotolia.com
Creating pollen-free trees to combat hay fever
11.8.2023 | Press monitoring
Japanese cedar (Cryptomeria japonica) pollen is a significant cause of the suffering in the 38.8% of Japanese people who are allergic. Japanese cedar is also the country's most important timber species. A single mature tree produces on the order of three hundred million grains of pollen. Saneyoshi Ueno and colleagues investigated the genes...
Credit: luchshen - Fotolia.com
Groundbreaking Epstein-Barr virus vaccine may prevent MS
9.8.2023 | Press monitoring
After a landmark study published last year found that the risk of developing multiple sclerosis (MS) increased 32-fold after infection with Epstein-Barr virus (EBV), researchers from QIMR Berghofer Medical Research Institute set about developing a vaccine against the virus. A member of the herpes family of viruses, EBV is carried by about 95% of...
First-of-its-kind nanoscale tattoo attaches to individual cells
7.8.2023 | Press monitoring
Researchers have created a nanoscale electronic ‘tattoo’ sensor that can attach to a live, individual cell without damaging it. The breakthrough development could be used to monitor cell health and puts us one step closer to getting the jump on disease diagnosis. Researchers from Johns Hopkins University built the tiny tattoo sensors out of gold...
Credit: Vlad_Egorov - Fotolia.com
A floating sponge could help remove harmful algal blooms
4.8.2023 | Press monitoring
In the peak heat of summer, beachgoers don't want their plans thwarted by harmful algal blooms (HABs). But current methods to remove or kill toxin-producing algae and cyanobacteria aren't efficient or practical for direct applications in waterways. Now, researchers reporting in ACS ES&T Water have coated a floating sponge in a charcoal-like...
Credit: Ramona Kaulitzki - Fotolia.com
Novel molecules fight viruses by bursting their bubble-like membranes
2.8.2023 | Press monitoring
Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers? "We found an Achilles heel of many viruses: their bubble-like membranes....
Credit: valpictures - Fotolia.com
Retina cells cultured on nanofiber scaffolds could help treat blindness
31.7.2023 | Press monitoring
Scientists have found a way to use nanotechnology to create a 3D "scaffold" to grow cells from the retina – paving the way for potential new ways treating a common cause of blindness. Researchers, led by Professor Barbara Pierscionek from Anglia Ruskin University (ARU), have been working on a way to successfully grow retinal pigment epithelial...
Credit: Karsten Bittner - Fotolia.com
Hydrangea compound inhibits buildup of Alzheimer\'s-associated protein
28.7.2023 | Press monitoring
Much recent research has concentrated on developing treatments to slow or reverse Alzheimer’s disease (AD). With studies suggesting a link between brain plaques caused by the aggregation of amyloid beta protein and cognitive decline, many potential treatments have focused on addressing this particular brain pathology. Now, researchers from...
